Melanoma May No Longer Be a Death Sentence

June 3 (Bloomberg) -- The next generation of experimental immune-boosting drugs from Merck, Bristol-Myers and Roche are producing such promising early results that doctors are openly speculating that some patients with the deadliest form of skin cancer may be cured. Olivia Sterns reports on Bloomberg Television's "Street Smart." (Source: Bloomberg)
Does Stock, Oil Volatility Impact Fed Rate Hike Plans?
25:09 - Bianco Research President Jim Bianco discusses Fed policy, the markets and financial stability. He speaks on "Bloomberg Markets." (Source: Bloomberg)
  • China Markets: Taking a Long View Past Volatility
  • El-Erian: U.S. Economy at Risk from Financial Volatility
  • 190,000 More Jobs Added in U.S. Last Month: ADP